0001181431-11-059292.txt : 20111207
0001181431-11-059292.hdr.sgml : 20111207
20111207163248
ACCESSION NUMBER: 0001181431-11-059292
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111205
FILED AS OF DATE: 20111207
DATE AS OF CHANGE: 20111207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001484478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271197863
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-456-7800
MAIL ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: PPD Therapeutics, Inc.
DATE OF NAME CHANGE: 20100218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COVINGTON PAUL S
CENTRAL INDEX KEY: 0001181153
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34641
FILM NUMBER: 111248870
MAIL ADDRESS:
STREET 1: 3116 BRAEMAR DRIVE
CITY: WILMINGTON
STATE: NC
ZIP: 28401
4
1
rrd327350.xml
FORM 4
X0304
4
2011-12-05
0
0001484478
Furiex Pharmaceuticals, Inc.
FURX
0001181153
COVINGTON PAUL S
C/O FURIEX PHARMACEUTICALS, INC.
3900 PARAMOUNT PARKWAY, SUITE 150
MORRISVILLE
NC
27560
0
1
0
0
Senior VP-Clinical Operations
Common Stock
2011-12-05
4
P
0
2850
17.68
A
2923
D
Stock Options (to buy)
9.11
2020-06-17
Common Stock
75691
75691
D
Stock Options (to buy)
15.00
2021-05-09
Common Stock
26000
26000
D
Stock Options (to buy)
13.16
2021-10-03
Common Stock
37944
37944
D
This transaction was executed in multiple trades at prices ranging from $17.75 to $17.98. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
/s/ Paul S. Covington
2011-12-07